[The 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), Milan, Italy, April 23-27, 2008].
Pár
Alajos
A
Pécsi Tudományegyetem, Altalános Orvostudományi Kar I. Belgyógyászati Klinika, Pécs. alajos.par@aok.pote.hu
Pár
Gabriella
G
D000970:Antineoplastic Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000517:prevention & control / Q000821:virology; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D005060:Europe; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008107:Liver Diseases / Q000175:diagnosis / Q000628:therapy; D008113:Liver Neoplasms / Q000188:drug therapy / Q000517:prevention & control / Q000821:virology; D009536:Niacinamide / Q000031:analogs & derivatives; D009842:Oligopeptides / Q000627:therapeutic use; D010349:Patient Compliance; D010671:Phenylurea Compounds; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011392:Proline / Q000031:analogs & derivatives / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use; D012955:Societies, Medical; D000077157:Sorafenib
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D001557:Benzenesulfonates; D003692:Delayed-Action Preparations; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D009842:Oligopeptides; D010671:Phenylurea Compounds; D011725:Pyridines; D011994:Recombinant Proteins; D009536:Niacinamide; D011092:Polyethylene Glycols; D012254:Ribavirin; C486464:telaprevir; C512204:N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide; D011392:Proline; D000077157:Sorafenib; C100416:peginterferon alfa-2a